How do you use serum IgG levels when treating with FcRN inhibitors?

Discuss the cases and questions guidelines don't cover.

Related Questions

What treatments, after appropriate dose reductions/delays, do you offer for patients with oxaliplatin-induced cold allodynia/dysesthesia?

When should you avoid initiating beta blockers in a patient with myasthenia gravis?

What is your approach to escalating therapies for stiff person syndrome that is refractory to IVIG and steroids?

What is your treatment approach to autoimmune autonomic ganglionopathy (AAG)?

For patients who develop IVIG aseptic meningitis, how do you approach future IVIG treatments?

Evidence Meets Expertise